A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

[Effect of Dahuang Zhechong pills on arterial thrombosis in rabbits]. | LitMetric

[Effect of Dahuang Zhechong pills on arterial thrombosis in rabbits].

Zhong Nan Da Xue Xue Bao Yi Xue Ban

Department of Integrated Chinese and Western Medicine, Engineering Center of Screening Traditional Chinese Medicine, Xiangya Hospital, Central South University, Changsha, China.

Published: September 2009

AI Article Synopsis

  • The study evaluated the impact of Dahuang Zhechong pills (DZ) on arterial thrombus formation in rabbits, comparing it with established treatments like aspirin and clopidogrel.
  • Results showed that higher doses of DZ led to a significant reduction in thrombus weight and improved vessel conditions compared to the model group, indicating effectiveness in dissolving clots.
  • Overall, Dahuang Zhechong pills could be a promising new option for treating arterial thrombosis, showing similar effects to standard anticoagulant medications.

Article Abstract

Objective: To investigate the effect of Dahuang Zhechong pills (DZ) on arterial thrombotic model in vivo.

Methods: Sixty-five rabbits were randomly divided into 7 groups: normal, model (collagen encapsulated thread-drawing),model+aspirin (ASA), model+clopidogrel (CP),model+ASA+CP, model+ low dosage DZ (DZL), and model+high dosage DZ (DZH). All rabbits except the normal group were fed with the drugs repectively for 8 days,and sacrificed at 2 hours after the last feeding, obtained aortae. The pathological changes in the aortae were observed under microscope,and the level of FDP, D-dimer and tissue factor (TF) were measured by enzyme-linked immunosorbent assay (ELISA).

Results: The vascular vessels were filled with thrombi in the model group and the elastic membranes of the vessel wall were seriously injured. The arterial thrombi were observed around the vascular wall in the DZL group, but some of the thrombi were dissolved. The number of thrombi was remarkably decreased in the DZH group, and most thrombi were dissolved and the vascular intimal membranes were intact. Compared with the model group, the dry and wet weight of the thrombi and the level of D-dimer, FDP, and TF in the plasma were significantly attenuated (P<0.01) in all the treatment groups. There were no significant difference between the DZL group and the ASA group in the dry weight, D-Dimer, and FDP (P>0.05). The pathological changes in the vascular vessel and the elevation of plasma parameters in the DZL group were similar to those in the ASA and CP groups (P>0.05). The dry and wet weight, D-dimer, FDP, and TF in the plasma in the DZH group were significantly lower than those in the DZL group (P<0.01 or P<0.05, separatively), and closed to those in the ASA+CP group.

Conclusion: Dahuang Zhechong pills are potential novel anti-thromobotic agent for arterial thrombosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dzl group
12
dahuang zhechong
8
zhechong pills
8
pills arterial
8
group
8
pathological changes
8
model group
8
group thrombi
8
thrombi dissolved
8
dzh group
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!